Additional file 2: of l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia

Summary of patients who underwent HSCT after SMILE or VIDL chemotherapy. One patient underwent autologous HSCT and 7 patients received allogeneic HSCT. No engraftment failure or treatment-related mortality occurred. But, 2 patients died from disease relapse (Autologous; 1, Allogeneic; 1). (DOCX 17 kb)